Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Non Operating Income (2021 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Non Operating Income came in at -$14.7 million in Q1 2026, down 296074.34% YoY from N/an in Q1 2025, and up 33.17% on a QoQ basis from -$22.0 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Non Operating Income (2021 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 6 years of Non Operating Income data on file, last reported at -$14.7 million in Q1 2026.

  • Quarterly Non Operating Income fell 296074.34% year-over-year to -$14.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36.7 million (down 24565.74% YoY) and the FY2025 annual result came in at -$22.0 million, down 9412.05% from the prior year.
  • Non Operating Income climbed to -$14.7 million in Q1 2026, from -$22.0 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $91194.0 in Q1 2024 to a low of -$22.0 million in Q4 2025.
  • A 5-year average of -$2.7 million and a median of $25532.5 in 2023 frame the typical range for Non Operating Income.
  • Annual changes were most pronounced in 2024 — Non Operating Income soared 249.27% — and 2026, when it plunged 296074.34%.
  • Tracing CNTN's Non Operating Income over 5 years: stood at -$1.6 million in 2022, then jumped by 103.61% to $57379.0 in 2023, then sank by 53.09% to $26914.0 in 2024, then tumbled by 81804.72% to -$22.0 million in 2025, then jumped by 33.17% to -$14.7 million in 2026.
  • The last three Non Operating Income figures came in at -$14.7 million (Q1 2026), -$22.0 million (Q4 2025), and -$8260.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 234.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -139.24 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -53.64 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -51.63 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - -23.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.42 Mn
Mar 31, 2026 -14.70 Mn
Dec 31, 2025 -21.99 Mn
Sep 30, 2025 -8,260.00
Jun 30, 2025 -3,993.00
Mar 31, 2025 4,965.00
Dec 31, 2024 26,914.00
Sep 30, 2024 69,719.00
Jun 30, 2024 48,397.00
Mar 31, 2024 91,194.00
Dec 31, 2023 57,379.00
Sep 30, 2023 24,955.00
Jun 30, 2023 27,682.00
Mar 31, 2023 26,110.00
Mar 31, 2022 -1.59 Mn
Dec 31, 2021 2.55 Mn
Sep 30, 2021 -312,323.00
Jun 30, 2021 -458,371.00
Mar 31, 2021 -782,463.00